CAMBRIDGE, Mass.--(BUSINESS WIRE)--CombinatoRx, Incorporated (Nasdaq: CRXX), today announced its goals and guidance for 2008.
“2008 promises to be an exciting and pivotal year for CombinatoRx with clinical data expected from CRx-102, 191, 197 and 401,” said Alexis Borisy, President and CEO of CombinatoRx. “We also continue to maintain a steady flow of novel programs into clinical development, remain on track for our 2008/2009 partnering campaign and have sufficient capital to execute on our business plan.”
